HBIO - Harvard Bioscience, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue104,521108,664108,663
Cost of Revenue56,10659,94159,319
Gross Profit48,41548,72349,344
Operating Expenses
Research Development5,3926,4204,880
Selling General and Administrative42,62640,40935,051
Non Recurring6727881,027
Others2,7222,8192,578
Total Operating Expenses51,41250,43643,536
Operating Income or Loss-2,997-1,7136,618
Income from Continuing Operations
Total Other Income/Expenses Net561-1,041-401
Earnings Before Interest and Taxes-2,436-2,7545,407
Interest Expense642854990
Income Before Tax-3,078-3,6084,417
Income Tax Expense1,22915,4312,062
Minority Interest---
Net Income From Continuing Ops-4,307-19,0392,355
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-4,307-19,0392,355
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-4,307-19,0392,355